Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 994, pseudogene (abbreviated RNU6-994P), is a human pseudogene annotated as an unprocessed, noncoding RNA locus located on chromosome 20[3][5]. It does not encode a protein and is considered a processed pseudogene derived from small nuclear RNA (snRNA), specifically a member of the U6 snRNA family[3][5]. There is no evidence that RNU6-994P has been characterized functionally as a therapeutic or diagnostic target, nor has it been directly implicated in disease. However, pseudogenes in general can sometimes regulate gene expression—by serving as competitive endogenous RNAs or miRNA decoys, or generating regulatory noncoding RNAs[2][4]. No such functional data exists for RNU6-994P specifically, and there are no known disease, drug, or biomarker associations for this locus. RNU6-994P is best classified as a noncoding, non-functional genomic element with possible, but unconfirmed, regulatory roles. The lack of aliases, functional annotation, or disease relevance, and its classification as a pseudogene means it is not a valid therapeutic target[3][5][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 994, pseudogene (RNU6-994P).